News & Events
- / Uncategorized
BOSTON and VALENCIA, Feb. 14, 2024 – Curapath, a leader in the development and custom manufacturing of polymer- and lipid-based delivery systems for advanced therapies, has...
- / Uncategorized
Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer....
- / Uncategorized
Valencia, Spain and Boston, MA, January 26, 2023 – Curapath, a leader in the design, development, andcustom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems...
- / Uncategorized
Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine Valencia, Spain and Boston, MA, November 16, 2022 – Curapath, a...
- / Uncategorized
Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation Addition of late stage clinical and commercial-scale production is also planned Company...
Proyecto cofinanciado por los Fondos FEDER, dentro del Programa Operativo FEDER de la Comunidad Valenciana 2021-2027
Desarrollo de nuevas plataformas de lípidos y su optimización en el uso de nanopartículas lipídicas para el transporte de material genético
PROGRAMA: AYUDAS PARA PROYECTOS DE I+D PYME PIDI-CV Nº Expediente: IMIDTA/2023/73
Proyecto subvencionado por el CDTI y apoyado por el Ministerio de Ciencia e Innovación
Investigación de nueva vacuna para enfermedad respiratoria humana
(VSRVAC)
PROGRAMA: Programa Misiones Empresas
Nº Expediente: EXP 00146282 / MIG-20211034
